| __timestamp | Ascendis Pharma A/S | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 152500000 |
| Thursday, January 1, 2015 | 40528000 | 187800000 |
| Friday, January 1, 2016 | 66022000 | 184000000 |
| Sunday, January 1, 2017 | 99589000 | 167700000 |
| Monday, January 1, 2018 | 140281000 | 218600000 |
| Tuesday, January 1, 2019 | 191621000 | 187400000 |
| Wednesday, January 1, 2020 | 260904000 | 177700000 |
| Friday, January 1, 2021 | 295867000 | 122000000 |
| Saturday, January 1, 2022 | 379624000 | 123100000 |
| Sunday, January 1, 2023 | 413454000 | 122500000 |
| Monday, January 1, 2024 | 307004000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. Ascendis Pharma A/S and Perrigo Company plc, two prominent players, showcase contrasting approaches to research and development (R&D) spending over the past decade. Ascendis Pharma A/S has consistently increased its R&D investment, growing from approximately 20% of its 2023 spending in 2014 to a staggering 100% by 2023. This reflects a robust commitment to innovation, with a compound annual growth rate of around 40% in R&D expenses. In contrast, Perrigo Company plc has maintained a more conservative approach, with R&D spending peaking in 2018 and then declining by about 44% by 2023. This divergence highlights Ascendis Pharma's aggressive pursuit of innovation, while Perrigo focuses on optimizing existing resources. As the pharmaceutical landscape continues to shift, these strategies will undoubtedly shape their future trajectories.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Genmab A/S or Perrigo Company plc: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Gross Profit Comparison: Ascendis Pharma A/S and Perrigo Company plc Trends
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Perrigo Company plc and Xenon Pharmaceuticals Inc.